Immunotherapy in Advanced Prostate Cancer: Current Knowledge and Future Directions

The advent of immunotherapy has revolutionized cancer treatment. Unfortunately, this has not been the case for metastatic castration-resistant prostate cancer (mCRPC), likely due to the heterogeneous and immune-suppressive microenvironment present in prostate cancer. The identification of molecular...

Descripción completa

Detalles Bibliográficos
Autores principales: López-Campos, Fernando, Gajate, Pablo, Romero-Laorden, Nuria, Zafra-Martín, Juan, Juan, Manel, Hernando Polo, Susana, Conde Moreno, Antonio, Couñago, Felipe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945350/
https://www.ncbi.nlm.nih.gov/pubmed/35327339
http://dx.doi.org/10.3390/biomedicines10030537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945350/
https://www.ncbi.nlm.nih.gov/pubmed/35327339
http://dx.doi.org/10.3390/biomedicines10030537

Ejemplares similares